51

Academics

Repeated External Pneumatic Compression Treatments Effects ...

Repeated External Pneumatic Compression Treatments Effects ...

Academics NAVIGATION

Repeated External Pneumatic Compression Treatments Effects on Exercise Performance and Recovery

LU IRB#: IRB-23-36
PI: Petey Mumford, PhD

Repeated External Pneumatic Compression Treatments Effects on Exercise Performance and RecoveryDescription of Study

The purpose of this study is to examine how treatment with different types of external pneumatic compression devices affects recovery following a strenuous lower leg exercise bout.

Location
(Fieldhouse 126) and Fieldhouse 110
209 S Kingshighway St
Saint Charles, MO 63301

Number of Visits
6

Time Commitment
Visit 1: 20 minutes;
Visit 2: 1 hour (Can be combined with Visit 1 - Dependent on Oura ring size);
Visit 3: 2 hours;
Visits 4-6: 4.5 hours each

Compensation
$300 (Direct Deposit)

Point of Contact
Connor Gaige
epnl@lindenwood.edu

Research Sample Needed

  • 60 healthy, males and females.

Inclusion Criteria

  • In good health absent of being overweight or mildly obese with no other signs or symptoms of cardiovascular, respiratory, metabolic, immune, psychiatric, or musculoskeletal disease or disorders.
  • Between the ages of 21 - 45 (no more than 30% of the participants will be under the age of 25).
  • Participating in a structured exercise program ≥ 3 days/week.
  • BMI is ≤ 30 kg/m^2 and body fat ≤30%.
  • Not taking any vasoactive, glycemic-control, pain management related medications or supplements.
  • Willing and able to agree to the requirements and restrictions of this study, be willing to give voluntary consent, and carry out all study-related procedures.
  • Has a smart phone to sync data via Bluetooth to Oura ring app.
  • Has a ring size that fits the Oura ring sizes we have ordered.

Exclusion Criteria

  • Positive medical history and/or is currently being treated for some form of heart disease, cardiovascular disease.
  • Currently being treated for kidney disease, renal failure, or has dialysis performed on regular intervals.
  • Has liver disease or some form of clinically diagnosed hepatic impairment.
  • Diagnosed with having Type I or Type II diabetes.
  • Diagnosed with major affective disorder or other psychiatric disorder that required hospitalization in the prior year.
  • Diagnosed with some form of immune disorder (i.e., HIV/AIDS).
  • History of cancer (except localized skin cancer without metastases or in situ cervical cancer within 5 years prior to screening visit).
  • Positive medical history for any neurological condition or neurological disease.
  • Currently prescribed a statin drugs (i.e., Lipitor, Livalo, Crestor, Zocor, etc.) or any hypertension medications (i.e., Beta-blockers, ACE Inhibitors, Alpha blockers, Vasodilators, etc.).
  • Current smoker (average of > 1 pack per day within the past 3 months) or has quit within the past six months. This includes all forms of nicotine.
  • Intake of any drugs (prescribed or over the counter) or dietary supplements that are vasoactive, glycemic-controlling, or pain management.
  • Participants who are lactating, pregnant or planning to become pregnant.
  • Outside of the age range.
  • Not participating in a structured exercise program ≥ 3 days/week.
  • BMI is not ≤ 30 kg/m^2 and body fat is > 30%.
  • Is taking medication or supplements that would interfere with study outcomes.
  • Does not have a smart phone to sync data via Bluetooth to Oura ring app.
  • Ring size is too small or big for an Oura ring, or they have a ring size that does not fit the rings we have ordered.

Are You Eligible?

  • .

Information provided here reflects current IRB approval for this research. However, this information may be subject to change and updated accordingly.